Abstract-The effects of 8-(2-dimethylaminoethyl)-3-oxo-4-phenyl-1-thia-4,8 diazaspiro [4, 5] decane dihydrochloride monohydrate (Y-8845) on carbon tetra chloride (CC14)-induced liver injury were investigated in rats. CC14-induced attenuation of the plasma cyclic AMP (cAMP) response to glucagon stimulation was significantly prevented by pretreatment with Y-8845.
Abstract-The effects of 8-(2-dimethylaminoethyl)-3-oxo-4-phenyl-1-thia-4,8 diazaspiro [4, 5] decane dihydrochloride monohydrate (Y-8845) on carbon tetra chloride (CC14)-induced liver injury were investigated in rats. CC14-induced attenuation of the plasma cyclic AMP (cAMP) response to glucagon stimulation was significantly prevented by pretreatment with Y-8845.
Y-8845 also effectively suppressed the increases in the activities of serum transaminases as well as the decreases in microsomal glucose-6-phosphatase activity and microsomal cy tochrome P-450 concentrations induced by CC14. In rats at 72 hr after CCI4 administration, the plasma cAMP response to glucagon, microsomal glucose-6 phosphatase activity and P-450 concentration were all below the control level. Y-8845 treatment after CCI4 administration rectified these reductions to nearly normal levels. Furthermore, Y-8845 stimulated DNA synthesis during liver rege neration after CCI4 intoxication.
These results demonstrate that Y-8845 has a protective effect against CCI4-induced injury in the liver and a stimulating effect on the recovery of the damaged liver.
A new compound, 8-(2-dimethylamino ethyl)-3-oxo-4-phenyl-1-thia-4,8-diazaspiro [4, 5] decane dihydrochloride monohydrate (Y-8845; the chemical structure of which is shown in Fig. 1 ) has been reported to have a hepatoprotective effect on various kinds of experimental injuries (1) . Pretreatment with Y-8845 is said to reduce the increases in serum transaminase activities induced by carbon tetrachloride (CCI4), thioacetamide, D-galactosamine, a-naphtylisothiocyanate and endotoxin (1) . Furthermore, it has been found that Y-8845 demonstrates anti-fibrotic action on egg yolk-induced chronic fibrosis (1). However, the effects of Y-8845 on the recovery of liver after intoxication are as yet less well defined.
Recently, it has been reported that the cyclic AMP (cAM P) response to glucagon and DNA synthesis in liver may be a valuable indicator for the recovery of hepatic injury (2) . The aim of the present study is to provide further information as to the effects of Y-8845 on protection against and the acceleration of recovery from hepatic injury in CCI4-intoxicated rats. Determination of plasma cAMP level: Under pentobarbital anesthesia, blood specimens (0.05 ml) were taken from the tail vein at intervals of 10 min before and after the injection of glucagon (100 iig/kg, s.c.) and were immediately mixed with 0.2 ml of saline containing 10 mM EDTA. After centrifugation, the supernatant (0.1 ml) was analyzed for cyclic AMP by radioimmuno assay (4) using a commercial assay kit (Yamasa, Japan).
Determination of hepatic DNA synthesis: DNA synthesis in liver was determined as described previously (2) . In brief, rats were injected intraperitoneally with 5 ,eCi (methyl 3H)thymidine per 100 g body weight and killed 1 hr later. DNA was extracted from the liver homogenate as described by Munro and Fleck (5), and the amount of radioactivity incorporated into DNA was measured by counting on a Beckman LS 9000 scintillation spectrometer.
DNA was measured by the method of Martin et al. (6) using calf thymus DNA standards.
3H-Thymidine in corporated into liver DNA was expressed as cpm/mg DNA.
Determination of enzyme activities: G6Pase activity in hepatic microsomes was measured as described by Swanson (7) and liberated inorganic phosphate was measured by the method of Ames (8) . Glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) activities in serum were determined using a commercial assay kit (latron, Tokyo). Cytochrome P-450 content in microsomal preparations was measured according to the procedure described by Omura and Sato (9) .
Results are expressed as the mean±S.E. Statistical significance of difference was determined by the use of Student's t-test.
The sources of materials used in this study were as follows: (Methyl-3H)thymidine (25 Ci/mmol) from the Amersham Corp., glu cagon and D-glucose-6-phosphate disodium from Sigma Chemical Co. Y-8845 was a gift from Yoshitomi Pharmaceutical Ind. Co. All other reagents were of analytical grade.
Results
Protective effects of Y-8845 against CC14 induced liver injury: The protective action of Y-8845 against CCI4-induced liver injury was observed in the changes in serum GOT and GPT activities. As shown in Fig. 2 , a marked elevation of serum GOT and GPT activities in rats resulted from CCI4 intoxication 24 hr after the toxin administration.
The pretreat ment of rats with Y-8845 (30 or 100 mg/kg) significantly inhibited the development of CCI4-induced elevations of serum trans aminase activities. Although both liver microsomal G6Pase activity and cytochrome P-450 content were markedly decreased at 24 hr after CCI4 administration, Y-8845 (100 mg/kg) given 30 min before CCI4 signifi cantly suppressed the CCI4-induced re ductions of G6Pase activity and P-450 content (Fig. 3) . As a parameter to observe the state of hepatic plasma membrane functions (10), the changes of plasma cAMP levels after glucagon injection were in vestigated in CCI4-intoxicated rats with or without Y-8845 pretreatment.
These results are shown in Table 1 . When glucagon (100 itg/kg, s.c.) was injected into normal rats, plasma cAMP strikingly increased and reached a peak (4.2 times higher than the basal plasma level) at 20 min after the injection. This glucagon-induced response in the plasma cAMP level was almost abolished in rats at 24 hr after CCI4 administration. 
.). S-GOT(A) and S GPT(B) were measured 24 hr after CCI4 administration.
Each value is given as the mean±S.E. of 7-8 rats. *P<0.05, **P<0.01, compared with saline+CCI4. Fig. 3 . Effects of Y-8845 on microsomal content of cytochrome P-450 (Cyt. P-450) (A) and glucose 6-phosphatase (G6Pase) activity (B) in rats at 24 hr after CCI4 administration. Y-8845 at 100 mg/kg (Y(100)) was injected intraperitoneally 30 min before the administration of CCI4. Hepatic microsomes were prepared from rats at 24 hr after CCI4 administration, and P-450 content and G6Pase activity were measured.
Each bar represents the mean±S. In rats at 72 hr after CCI4 intoxication, the plasma cAM P response to glucagon remained lower than in control rats. As shown in Table  2 , treatment with Y-8845 (100 mg/kg) at 24 and 36 hr or at 24, 36, 48 and 60 hr after CCI4 administration manifested a pronounced tendency to improve the toxin-induced impairment in cAMP response to glucagon.
The capacity of recovery from the CC14 injury was examined by measurement of DNA synthesis. Figure 4 shows the effect of Y 8845 on hepatic DNA synthesis in CC14 treated rats. The value of basal DNA synthesis (without the drug) in control rats was 1949 ±147 cpm/mg DNA. Though the DNA synthesis significantly increased (3622±342 cpm/mg DNA) 48 hr after CCI4 adminis tration, indicating liver regeneration after the intoxication (11 ) , administration of Y-8845 (30 or 100 mg/kg) to rats at 24 and 36 hr after the intoxication caused an enhancement of DNA synthesis.
However, even a large dose (100 mg/kg) of Y-8845 did not affect hepatic DNA synthesis in control animals. Also there was no appreciable difference in hepatic DNA synthesis between the Y-8845 (100 mg/kg) -treated and saline-treated animal groups at one week after CCI4 intoxication.
Microsomal G6Pase activity and cyto chrome P-450 content in rats at 72 hr after CCI4 intoxication were also lower than the values in control animals (Fig. 5) . However, a rapid recovery in G6Pase activity and cytochrome P-450 content toward the normal levels was observed in rats treated with Y 8845. Hepatic DNA synthesis was measured 48 hr and 1 week after the CCI4 administration. Each bar is given as the mean+S.E. of 6-8 rats. *P<0.05, **P<0.01, compared with CCI4+saline.
Discussion
In the present study, a single dose of Y 8845 (10-100 mg/kg) given 30 min before CCI4 significantly diminished the CC14 induced attenuation of the plasma cAMP response to glucagon (Table 1) . Glucagon, regulating hepatic glycogenolysis and gluco neogenesis through an increase in cellular cAMP (12, 13) , induces an elevation of the plasma cAMP by an increased efflux of the nucleotide from the liver (14) . In line with our previous report (2), the response was almost abolished at 24 hr after the toxin (Table  1) . Coincidently, the binding of glucagon to hepatic plasma membrane was diminished from 24 to 48 hr after the intoxication (15) . It may be considered that Y-8845 is capable of protection against CC14 induced damage on the hepatic plasma membrane. This supposition is supported by the facts that the CCI4-induced transaminase leakage from hepatocytes to plasma, the decrease in cytochrome P-450 and the reduction in G6Pase activity were attenuated by Y-8845 administration prior to the toxin (Figs. 2 and 3) . The mechanism of the protective action of Y-8845 is unclear at present. It is reported that the destruction of G6Pase of cytochrome P-450 by CC14 in vivo correlated with the enhancement of lipid peroxidation (16) . Therefore, the protective effect of Y-8845 against CC14 hepatotoxicity observed in this study might be partly ascribable to anti-peroxidation properties. Y-8845 at 100 mg/kg (Y(100)) was injected intraperitoneally 4 times at 24, 36, 48 and 60 hr after CC14 administration. Hepatic microsomes were prepared from rats at 72 hr after CC14 administration, and P-450 content and G6Pase activity were measured.
Each bar is given as the mean±S.E. of 5-6 rats. §P<0.01, § §P<0.001, compared with olive oil+saline. *P<0.05, compared with CC14+saline.
An improvement of the response to glu cagon was found with repeated adminis tration of Y-8845 to the intoxicated rats, but it was not statistically significant when compared with non-treated intoxicated animals. The injury of hepatocytes occurs synchronously in the early stages of CC14 intoxication (12-24 hr), but after the acute alteration of hepatocytes induced by a single dose of the toxin, cells in various stages of recovery from the damage may appear in the whole liver (17) . The glucagon-responses of these hepatocytes in various stages of recovery revealed no significant statistical differences between CC14-treated rats and those treated with olive oil, or between the intoxicated rats treated with Y-8845 and those given no drug (Table 2) .
In the present study, change of hepatic DNA synthesis was investigated as a hepatic response of repair from CC14-injury. Y-8845 given at 24 hr after CC14 potentiated hepatic DNA synthesis at 48 hr in the intoxicated rats (Fig. 4) , but this potentiating effect was not dose-dependent in the used dose range, suggesting the maximal response to the drug.
From our previous studies (2, 18) , it seems likely that hepatic DNA synthesis of rats given CC14 (1 ml/kg) reaches the maximal value at 48 hr and returns to roughly the normal level at 72 hr and that DNA synthesis in CC14-injured liver is more sensitive to stimulants (e.g., hormones and neuro transmitters) for a period of 24 to 48 hr after the intoxication. The absence of the dose dependency on potentiation of DNA syn thesis by the drug may have resulted from this sensitized state of CC14-injured liver, and the dose-dependency may be obtained with smaller doses of Y-8845. This assumption is supported by the facts that the second dose of Y-8845 did not augment the effect of the first dose on DNA synthesis and that Y-8845 failed to increase the DNA synthesis in one week-passed rats after CC14 administration. The accelerated DNA synthesis may promote a rapid recovery in cytochrome P 450 content and G6Pase activity, since these CC14-induced dysfunctions were prolonged until 72 hr after the CC14 intoxication.
The present study suggests that Y-8845 has both a protective action against CC14 induced injury and an action accelerating the recovery from CC14-induced damage.
